Hodgkin Lymphoma News and Research

RSS
Cancer patients are four times more likely to commit suicide

Cancer patients are four times more likely to commit suicide

Risk of heart attack and stroke is high in the months before cancer diagnosis, shows study

Risk of heart attack and stroke is high in the months before cancer diagnosis, shows study

Study: Survivors of childhood Hodgkin lymphoma have high risk of developing solid tumors

Study: Survivors of childhood Hodgkin lymphoma have high risk of developing solid tumors

Study: 39% of B cell lymphoma patients treated with CAR T therapy remain in remission

Study: 39% of B cell lymphoma patients treated with CAR T therapy remain in remission

Scientists use genetically engineered immune cells to fight Hodgkin and non-Hodgkin lymphoma cells

Scientists use genetically engineered immune cells to fight Hodgkin and non-Hodgkin lymphoma cells

New first-line treatment for peripheral T-cell lymphoma approved by FDA

New first-line treatment for peripheral T-cell lymphoma approved by FDA

Amgen announces presentation of new clinical data showcasing early oncology pipeline at ASH 2018

Amgen announces presentation of new clinical data showcasing early oncology pipeline at ASH 2018

Ten Allen Distinguished Investigators for 2018 announced by Paul G. Allen Frontiers Group

Ten Allen Distinguished Investigators for 2018 announced by Paul G. Allen Frontiers Group

Head and neck cancer survivors more likely to commit suicide

Head and neck cancer survivors more likely to commit suicide

Organic food may protect against cancers finds study

Organic food may protect against cancers finds study

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Verastem Oncology selects US Bioservices to dispense COPIKTRA capsules

Verastem Oncology selects US Bioservices to dispense COPIKTRA capsules

FLX Bio treats first patient in its Phase 1/2 clinical trial of FLX475 for treating various advanced cancers

FLX Bio treats first patient in its Phase 1/2 clinical trial of FLX475 for treating various advanced cancers

FDA lifts partial clinical hold that paused enrollment of new patients in tazemetosta clinical trials

FDA lifts partial clinical hold that paused enrollment of new patients in tazemetosta clinical trials

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

Cancer Australia releases new data on childhood cancer stage at diagnosis

Cancer Australia releases new data on childhood cancer stage at diagnosis